Combined HDL–BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis
Journal of Clinical Medicine · 26.03.2026 · 15 (7) · 2525
DOI: 10.3390/jcm15072525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 26.03.2026. Verfasst von Qinxue Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Clinical Specialty Construction Projects of China, National Natural Science Foundation of China, Natural Science Foundation of Chang Sha.
Abstract (Originalsprache)
Background/Objectives: Risk stratification in idiopathic pulmonary fibrosis (IPF) remains primarily based on physiological indices, yet increasing evidence suggests that systemic metabolic and nutritional vulnerability may influence outcomes in chronic interstitial lung disease.
Methods
In this longitudinal, single-center cohort, 211 patients with IPF were followed from diagnosis until death or last follow-up. Baseline lipid profiles and body mass index (BMI) were assessed. A metabolic–nutritional phenotype was constructed using high-density lipoprotein cholesterol (HDL) and BMI. Survival was analyzed using Kaplan–Meier and multivariable Cox models adjusted for GAP stage. Incremental prognostic value beyond the GAP index was evaluated using Harrell’s C-index and time-dependent ROC analysis.
Results
During a median follow-up of 29 months, 134 patients (63.5%) died. Lower HDL levels were associated with increased mortality in unadjusted analysis (HR = 1.45, 95% CI 1.03–2.04) but were not independently predictive after adjustment. In contrast, the combined HDL–BMI phenotype independently stratified mortality risk. Compared with HDL ≤ 1.0 mmol/L and BMI ≤ 24 kg/m2, patients with HDL > 1.0 mmol/L and BMI > 24 kg/m2 had significantly lower mortality (adjusted HR = 0.48, 95% CI 0.29–0.80), with stronger associations among those aged ≥ 65 years (adjusted HR = 0.37, 95% CI 0.18–0.74). The addition of HDL–BMI improved discrimination beyond GAP (C-index: 0.585 vs. 0.618; 36-month AUC: 0.633 vs. 0.675; NRI: 0.243).
Conclusions
The coexistence of HDL ≤ 1.0 mmol/L and BMI ≤ 24 kg/m2 identified a subgroup with poorer survival in IPF. This combined metabolic–nutritional phenotype improved mortality risk stratification beyond the GAP stage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
- Research Unit of Respiratory Disease, Central South University, Changsha 410011, China.
- The Clinical Medical Research Center for Pulmonary and Critical Care Medicine in Hunan Province, Changsha 410011, China.
- Diagnosis and Treatment Center of Respiratory Disease, Central South University, Changsha 410011, China.
- Clinical Medical Research Center for Systemic Autoimmune Diseases in Hunan Province, Changsha 410011, China.
ORCID-Profile: Hong Peng
Förderung
- National Key Clinical Specialty Construction Projects of China
- National Natural Science Foundation of China
- Natural Science Foundation of Chang Sha
- National Natural Science Foundation of China https://ror.org/01h0zpd94
Zitieren
APA
Shen, Q., Ouyang, X., Tan, Y., Zhang, Q., Hu, F., He, S., & Peng, H. (2026). Combined HDL–BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine, 15(7), 2525. https://doi.org/10.3390/jcm15072525
Vancouver
Shen Q, Ouyang X, Tan Y, Zhang Q, Hu F, He S, et al. Combined HDL–BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis. Journal of Clinical Medicine. 2026;15(7):2525. doi:10.3390/jcm15072525
BibTeX
@article{Shen2026,
author = {Shen, Qinxue and Ouyang, Xiaoli and Tan, Yuexin and Zhang, Qing and Hu, Feng and He, Shengyang and Peng, Hong},
title = {Combined HDL–BMI Phenotyping Provides Incremental Prognostic Value in Idiopathic Pulmonary Fibrosis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {7},
pages = {2525},
doi = {10.3390/jcm15072525}
}
EUVIMED